PhRMA CEO Steve Ubl discusses, PBM reform, the "pill penalty" with the administration and advocating for pharmaceutical ...

Expected out-of-pocket costs for commonly prescribed brand name medications have grown substantially for Medicare Part D ...

A new study from the USC Schaeffer Center shows that out-of-pocket costs for brand-name medications have increased sharply ...

House Democrats beat back a series of Republican amendments on party-line votes Wednesday, setting up a final vote on a ...

The Department of Justice has filed an appeals court brief supporting the right of Medicare officials to negotiate ...

The House Leader of the Opposition B.C. Conservatives has described the "unsurmountable" price paid by her family in the ...

CHICAGO—On the heels of his 2025 State of the State budget address, Governor Pritzker focused on one of his top legislative ...

While Trump's tariffs could have a broad impact on healthcare prices, it is likely they will not have the devastating result ...

Two Omaha women lost more than 300 lbs. combined with injections of a GLP-1 drug, which are used increasingly for weight loss ...

“Governor Maura Healey’s proposal, to increase costs for prescription drugs, is absolutely ‘ill’ advised. Healthcare costs in ...

Trump could either weaken the negotiations in a way that benefits the pharmaceutical industry, or try to achieve even deeper ...

Pharmacy benefits managers, or PBMs, are meant to act as a middleman between drug manufacturers and insurance companies to ...